Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance

Simultaneous resistance to an array of drugs with different cytotoxic activities is a property of Saccharomyces cerevisiae, in which the protein Pdr3p has recently been shown to play a role as a transcriptional regulator. We provide evidence that the yeast PDR3 gene, which encodes a zinc finger transcription factor implicated in certain drug resistance phenomena, is under positive autoregulation by Pdr3p. DNase I footprinting analyses using bacterially expressed Pdr3p showed specific recognition by this protein of at least two upstream activating sequences in the PDR3 promoter. The use of lacZ reporter constructs, a mutational analysis of the upstream activating sequences, as well as band shift experiments enabled the identification of two 5'TC CGCGGA3' sequence motifs in the PDR3 gene as consensus elements for the binding of Pdr3p. Several similar sequence motifs can be found in the promoter of PDR5, a gene encoding an ATP-dependent drug pump whose Pdr3p-induced overexpression is responsible for drug resistance phenomena. Recently one of these sequence elements was shown to be the target of Pdr3p to elevate the level of PDR5 transcription. Finally, we provide evidence in the absence of PDR1 for a PDR3-controlled transcriptional induction of the drug pump by cycloheximide and propose a model for the mechanism governing the transcriptional autoregulation of Pdr3p.

[1]  W. Zachariae,et al.  Expression of the transcriptional activator LAC9 (KlGAL4) in Kluyveromyces lactis is controlled by autoregulation , 1993, Molecular and cellular biology.

[2]  R. Mann,et al.  Negative autoregulation by Ultrabithorax controls the level and pattern of its expression. , 1993, Development.

[3]  D. Kinney,et al.  Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions. , 1986, Gene.

[4]  A. Goffeau,et al.  PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. , 1994, The Journal of biological chemistry.

[5]  D. Thiele,et al.  A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. , 1994, The Journal of biological chemistry.

[6]  II. Yeast sequencing reports. Sequence of a 12·7 kb segment of yeast chromosome II identifies a PDR‐like gene and several new open reading frames , 1992, Yeast.

[7]  A. Varshavsky,et al.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein , 1989, Nature.

[8]  H J Schüller,et al.  Regulatory gene INO4 of yeast phospholipid biosynthesis is positively autoregulated and functions as a transactivator of fatty acid synthase genes FAS1 and FAS2 from Saccharomyces cerevisiae. , 1992, Nucleic acids research.

[9]  B. O’Malley,et al.  Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements , 1989, Cell.

[10]  M Ptashne,et al.  Determinants of binding-site specificity among yeast C6 zinc cluster proteins. , 1993, Science.

[11]  J. Golin,et al.  Mutations in the yeast PDR3, PDR4, PDR7 and PDR9 pleiotropic (multiple) drug resistance loci affect the transcript level of an ATP binding cassette transporter encoding gene, PDR5. , 1994, Genetics.

[12]  P. Prentki,et al.  Two‐dimensional gel selection of protein binding sites on DNA , 1993, Electrophoresis.

[13]  A. Goffeau,et al.  Genetics and biochemistry of yeast multidrug resistance. , 1994, Biochimica et biophysica acta.

[14]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[15]  R. Morimoto,et al.  Activation of Heat Shock Gene Transcription by Heat Shock Factor 1 Involves Oligomerization, Acquisition of DNA-Binding Activity, and Nuclear Localization and Can Occur in the Absence of Stress , 1993, Molecular and cellular biology.

[16]  Paolo Sassone-Corsi,et al.  Rhythmic transcription and autoregulatory loops: Winding up the biological clock , 1994, Cell.

[17]  C. S. Parker,et al.  Yeast YAP1 encodes a novel form of the jun family of transcriptional activator proteins. , 1989, Genes & development.

[18]  T. A. Brown,et al.  A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. , 1990, Nucleic acids research.

[19]  C. Jacq,et al.  Connections between RNA splicing and DNA intron mobility in yeast mitochondria: RNA maturase and DNA endonuclease switching experiments , 1992, Molecular and cellular biology.

[20]  L. Fernandes,et al.  Overexpression of YAP2, coding for a new yAP protein, and YAP1 in Saccharomyces cerevisiae alleviates growth inhibition caused by 1,10-phenanthroline. , 1993, The Journal of biological chemistry.

[21]  M. Labouesse,et al.  A family of low and high copy replicative, integrative and single‐stranded S. cerevisiae/E. coli shuttle vectors , 1991, Yeast.

[22]  K. Murata,et al.  Transformation of intact yeast cells treated with alkali cations. , 1984, Journal of bacteriology.

[23]  J. Thorner,et al.  Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Parthun,et al.  The EGD1 product, a yeast homolog of human BTF3, may be involved in GAL4 DNA binding , 1992, Molecular and cellular biology.

[25]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[26]  A. Goffeau,et al.  Multiple or pleiotropic drug resistance in yeast. , 1991, Biochimica et biophysica acta.

[27]  P Chambon,et al.  Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1 , 1993, Molecular and cellular biology.

[28]  C. Sander,et al.  A yeast gene encoding a protein homologous to the human c-has/bas proto-oncogene product , 1983, Nature.

[29]  A. Goffeau,et al.  The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. , 1987, The Journal of biological chemistry.

[30]  W. S. Moye-Rowley,et al.  Transcriptional control of the yeast PDR5 gene by the PDR3 gene product , 1994, Molecular and cellular biology.

[31]  M. Goebl,et al.  Yeast bZip proteins mediate pleiotropic drug and metal resistance. , 1993, The Journal of biological chemistry.

[32]  J. Šubík,et al.  Mucidin resistance in yeast. Isolation, characterization and genetic analysis of nuclear and mitochondrial mucidin-resistant mutants of Saccharomyces cerevisiae. , 1977, European journal of biochemistry.

[33]  Jeffrey H. Miller Experiments in molecular genetics , 1972 .